6
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapy

, , , , , , , & show all
Pages 15-24 | Published online: 16 Apr 2010

  • Banchcreau J, Steinman RM, Dendritic cells and the control of immunity. Nature (1998) 392: 245-52.
  • Inaba K, Steinman RM, Protein-specific helper T-lymphocyte formation initiated by dendritic cells. Science (1985) 229: 475-9.
  • Hauser C, Katz SI, Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. Proc Natl Acad Sci USA (1988) 85: 5625-8.
  • Hsu FJ, Benike C, Fagnoni F et al, Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med (1996) 2: 52-8.
  • Nestle FO, Alijagic S, Gilliet M et al, Vaccination of melanoma patients with peptide- or tumor lysatec-pulsed dendritic cells. Nat Med (1998) 4:328-32.
  • Kugler A, Stuhler G, Walden P et al, Regression of human metastatic renal cell carcinoma after vaccination with rumor cell-dendritic cell hybrids. Nat Med (2000) 6: 332-6.
  • Young JW, Steinman RM, Accessory cell requirements for the mixed lymphocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells. Cell Immunol (1988) 111: 167-82.
  • Markowiex S, Engleman EG, Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest (1990) 85: 955-61.
  • Freudenthal PS, Steinman R, The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA (1990) 87: 7698-702.
  • Hart DNJ, Dendritic cells: unique leukocyte populations which control the primary immune response. Blood (1997) 90: 3245-87.
  • O'Doherty U, Pcng M, Gezelter S et al, Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology (1994) 82: 487-93.
  • Olweus J, BitMansour A, Warnke R et al, Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA (1997) 94: 12551-6.
  • Kohrgruber N, Halanck N, Groger M et al, Survival, maturation, and function of CD11c+ and CD11c+ peripheral blood dendritic cells arc differentially regulated by cytokines. J Immunol (1999) 163: 3250-9.
  • Rissoan MC, Soumelis V, Kadowaki N et al, Reciprocal control of T helper cell and dendritic cell differentiation. Science (1999) 283: 1183-6.
  • Gabrilovich Dl, Corak J, Ciernik IF et al, Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res (1997) 3: 483-90.
  • Lissoni P, Vigore L, Ferranti R et al, Circulating dendritic cells in early and advanced cancer patiets: diminished percent in the metastatic disease. J Biol Regul Homeost Agents (1999) 13: 216-19.
  • Harris J, Sandra D, Stewart T, Hyslop D. The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease. Cancer (1976) 37: 1058-69.
  • Hersh EM, Oppenheim JJ. Inhibition of in vitro lymphocyte transformation during chemotherapy in man. Cancer Res (1967) 27: 98-105.
  • Kempf RA, Mitchell MS, Effects of chemotherapeutic agents on the immune response. J. Cancer Invest (1984) 2: 459-66.
  • Kempf RA, Mitchell MS, Effects of chemotherapeutic agents on the immune response. II. Cancer Invest (1985) 3: 23-33.
  • Savary AC, Grazziuni ML, Melichar B et al, Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients. Cancer Immunol Immuother (1998) 45: 234-40.
  • Mehta-Damani A, Markowicz S, Engleman EG, Generation of antigen-specific CD4+ T cell lines from naive precursors. Eur J Immunol (1995) 25: 1206-11.
  • Markowicz S, Skurzak HM, Walewski J, A method for directly determining the number of dendritic cells and for evaluation of their function in small amounts of human peripheral blood. Arch Immunol Ther Exp (2001) 49: 51-7.
  • Takamizawa M, Rivas A, Fagnoni H et al, Dendritic cells that process and present nominal antigens to naive lymphocytes are derived from CD2+ precursors. J Immunol (1997) 158: 2134-42.
  • Robinson PR, Hatterson S, English N et al. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 29: 2769-78.
  • Fearnley DB, McLellan AD, Mannering SI et al. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy. Bloo (1997) 89: 3708-16.
  • Arpinati M, Green CL, Heimfeld S et al, Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood (2000) 95: 2484-90.
  • Pulendran B, Banchereau J, Burkeholder S et al, Flt-3 ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. Blood (2000) 165: 566-72.
  • Maraskovsky E, Daro E, Roux E et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood (2000) 96: 878-84.
  • Gazitt Y, Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoictic growth factors. Stem Cells (2000) 18: 390-8.
  • Gazitt Y, I Liu Q, Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients. Stem Cells (2001) 19: 37-45.
  • Santiago-Schwarz F, Belilos E. Diamond B, Carsons SE, TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. 7 Leuk Biol (1992) 52: 274-81.
  • Reid CDL, Stackpoole A, Meager A, Tikerpac J, Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol (1992) 149: 2681-8.
  • Caux C, Dezutter-Dambuyam C, Schmirt D, Banchercau J, GMCSF and TNF-a cooperate in the generation of dendritic Langerhans cells. Nature (1992) 360: 258-61.
  • Young JW, Szaboles P, Moore MAS, Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor a. J Exp Med (1995) 182: 1111-19.
  • Menctrier-Caux C, Montmain G, Dieu MC et al, Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleutkin-6 and macrophage colony-stimulating factor. Btood (1998) 92: 4778-91.
  • Szaboles P, Avigan D, Gezelter S et al, Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood (1996) 87: 4520-30.
  • Ferlazzo G, Spaggiari GM, Semino C et al, Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ mycloid precursors. Eur J Immunol (2000) 30: 827-33.
  • Fanger HA, Wardwell K, Shen L et al, Type I (CD64) and type II (CD32) Fcy receptor-mediated phagocytosis by human blood dendritic cells. J Immunol (1996) 157: 541-8.
  • Fearnley DB, Whyte I.F, Carnoutsos SA et al, Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Biol (1999) 93: 728-36.
  • Mehta-Damani A, Markowicz S, Engleman HG, Generation of antigen-specific CDS+ CTLs from naive precursors. J Immunol (1994) 153: 996-1003.
  • Rondelli D, Andrews RG, Hansen JA et al, Alloantigen presenting function of normal human CD34+ hematopoietic cells. Blood (1996) 88:2619-25.
  • Muckall CL, Fleisher TA, Brown MR et al, Age, thymopoiesis, and CD4+ T-lymphocyte regeration after intensive chemotherapy. New Engl J Med (1995) 332: 143-9.
  • Mackall CL, Fleisher TA, Brown MR et al, Distinctions between CDS+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood (1997) 89: 3700-7.
  • Galy A, Rudraraju S, Baynes R, Klein J, Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation. Bone Marrow Transplant (2000) 25: 1249-55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.